Latest News about JUNO
Recent news which mentions JUNO
Report: Airbnb Wants SEC Rules Changed To Give Hosts Company Equity
September 21, 2018
Tickers
SEC
From Benzinga
Editas Prepares for the Commercialization of EDIT-101
August 09, 2018
From Motley Fool
3 Top Stocks Wall Street Is Overlooking
March 13, 2018
From Motley Fool
Editas Medicine Delivers Another Strong Quarter
March 07, 2018
From Motley Fool
From Benzinga
Investor Movement Index February Summary
March 06, 2018
From Benzinga
3 Biotech Stocks That Soared This Week: Are They Buys?
February 24, 2018
From Motley Fool
3 Big Drugmakers Boosting Huge R&D Budgets
February 23, 2018
From Motley Fool
The 1 Stock You've Been Overlooking for Your Roth IRA
February 20, 2018
From Motley Fool
How Celgene Hopes to Cash In on CAR-T
February 17, 2018
From Motley Fool
5 Things You Need to Know About Celgene's Future
February 15, 2018
From Motley Fool
3 Great Acquisition Targets for Gilead Sciences -- and 1 Iffy Candidate
February 14, 2018
From Motley Fool
Better Buy: Amgen Inc. vs. Celgene
February 11, 2018
From Motley Fool
Why Biotech Stocks Soared in Trump's First Year in Office
February 11, 2018
From Motley Fool
Here's Why bluebird bio Soared 15% in January
February 06, 2018
From Motley Fool
Why Juno Therapeutics Stock Screamed Higher in January
February 05, 2018
From Motley Fool
5 Top Stocks to Buy in February
February 04, 2018
From Motley Fool
3 Top Biotherapeutics Stocks to Buy Now
February 01, 2018
From Motley Fool
Is Celgene's Big Bet on CAR-T Smart?
February 01, 2018
From Motley Fool
Attention Biotech Investors: February PDUFA Catalysts Come Calling
January 31, 2018
From Benzinga
The Best Arthritis Drug/Treatment Stocks on the Market Right Now
January 30, 2018
From Motley Fool
Celgene Looking Good With Plans for More Growth
January 30, 2018
From Motley Fool
Gilead Sciences Outlook Brightens; Citi Upgrades
January 30, 2018
From Benzinga
3 Biotech Stocks to Buy for 2018
January 28, 2018
From Motley Fool
Better Buy: Intrexon Corporation vs. Celgene
January 28, 2018
From Motley Fool
3 Small Biotechs That Big Drugmakers Are Probably Drooling Over
January 28, 2018
From Motley Fool
From Motley Fool
Big Biotech Is Bustling With Buyouts
January 27, 2018
From Motley Fool
5 Things Celgene's Management Just Said That You'll Want to Know
January 26, 2018
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.